Arcosa, Inc. (ACA) Stock Forecast Oct. 29, 2026
Analysis updated on Oct. 29, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Arcosa, Inc. (ACA) stock forecast summary
This forecast was produced 6 trading days ago and has not been refreshed since; read it as historical, not as a current view.
Arcosa, Inc. is a mid-cap company with a market capitalization of $7.32B. It ranks number 2 by market capitalization among the 5 Fabricated Structural Metal Products issuers in our coverage with a current forecast.
For ACA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 37.0%, measured on 358 forecast dates between 2022-08-11 and 2026-07-31 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 33.0%, measured on 400 forecast dates between 2022-08-11 and 2026-09-29. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
ACA price chart and AI forecast
How ACA ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Arcosa, Inc. (ACA) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Fabricated Structural Metal Products peers listed below that report each metric.
Valuation & Market
| Metric | ACA | Rank |
|---|---|---|
| Market Cap | $7.32B | 2/5 |
| P/E Ratio | 15.39x | – |
| P/B Ratio | 2.46x | – |
| Dividend Yield | 0.14% | – |
| EPS | $9.69 | – |
| Book Value/Share | $60.75 | – |
| Revenue/Share | $55.90 | – |
| FCF/Share | $2.75 | – |
Profitability & Margins
| Metric | ACA | Rank |
|---|---|---|
| ROE | 16.5% | – |
| ROA | 9.3% | 2/5 |
| ROIC | 6.7% | 2/5 |
| Gross Margin | 23.0% | 3/5 |
| Operating Margin | 11.8% | 2/5 |
| Net Margin | 17.9% | 1/5 |
| EBT Margin | 8.3% | 2/5 |
| Tax Rate | 13.1% | – |
Financial Health
| Metric | ACA | Rank |
|---|---|---|
| Current Ratio | 3.12x | 2/5 |
| Quick Ratio | 2.31x | 2/5 |
| D/E Ratio | 0.78x | – |
| Financial Leverage | 1.78x | – |
| Interest Coverage | 3.6x | 4/5 |
| Working Capital | $959M | 2/5 |
Cash Flow
| Metric | ACA | Rank |
|---|---|---|
| Operating Cash Flow | $341M | 2/5 |
| Free Cash Flow | $135M | 3/5 |
| Capital Spending | -$206M | 5/5 |
| OCF Growth YoY | -23.1% | 5/5 |
| FCF Growth YoY | -54.0% | – |
| FCF/Sales | 4.9% | 4/5 |
| CapEx/Sales | 7.5% | 2/5 |
Operational Efficiency
| Metric | ACA | Rank |
|---|---|---|
| Asset Turnover | 0.52x | 5/5 |
| Receivables Turnover | 4.9x | 5/5 |
| Inventory Turnover | 5.8x | 4/5 |
| Fixed Assets Turnover | 1.3x | 5/5 |
| Days Sales Outstanding | 74 days | 1/5 |
| Days Inventory | 63 days | 2/5 |
| Payables Period | 39 days | – |
| Cash Conversion Cycle | 99 days | – |
Income Statement
| Metric | ACA | Rank |
|---|---|---|
| Total Revenue | $2.74B | 2/5 |
| Operating Income | $323M | 2/5 |
| Net Income | $491M | 2/5 |
| SG&A Expense | $325M | 2/5 |
| Cost of Goods Sold | $2.11B | 2/5 |
Dividend & Shareholder Information
| Metric | ACA | Rank |
|---|---|---|
| Dividends Per Share | $0.20 | – |
| Payout Ratio | 2.1% | – |
| Shares Outstanding | 49M | – |
| Net Income Growth | 433.0% | – |
| EPS Growth | 340.4% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.41B | 26.6% of assets |
| Cash & Short-term Investments | $432M | 8.1% of assets |
| Accounts Receivable | $559M | 10.5% of assets |
| Inventory | $364M | 6.9% of assets |
| Total Liabilities | $2.32B | 43.7% of assets |
| Short-term Debt | $229M | 4.3% of assets |
ACA quarterly financials and insider trading
Arcosa, Inc. (ACA) industry peers
Companies classified under the same SEC industry code as Arcosa, Inc. (Fabricated Structural Metal Products): 4 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere ACA sits on the market map
Arcosa, Inc. (ACA) stock news
Loading...
Arcosa, Inc. (ACA) stock forecast FAQ
What is the Arcosa, Inc. (ACA) stock forecast?
This forecast was produced 6 trading days ago and has not been refreshed since; read it as historical, not as a current view.
How accurate are Arcosa, Inc. stock predictions?
For ACA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 37.0%, measured on 358 forecast dates between 2022-08-11 and 2026-07-31 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 33.0%, measured on 400 forecast dates between 2022-08-11 and 2026-09-29. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Arcosa, Inc. forecasts updated?
Arcosa, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 29, 2026.
Which companies are Arcosa, Inc.'s industry peers?
4 issuers in our coverage, ACA included, share the SEC industry code Fabricated Structural Metal Products. The largest are: Valmont Industries Inc (VMI), Proto Labs Inc (PRLB), Innovate Corp. (VATE), Techprecision Corp (TPCS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.